Anorexia nervosa (AN) is an enigmatic syndrome affecting approximately 0.1% of the at risk population in the UK which equates to approximately 70 000 sufferers. Data from a number of studies have demonstrated the heritability of this disorder, however it is only in the last few years that studies have begun to determine the involvement of particular candidate genes in this genetic predisposition. In the current study we have used classical case-control association analysis to determine whether two highly polymorphic microsatellite markers, located within a 3-cM region of the UCP-2/UCP-3 locus, show involvement of this region of the human genome in the predisposition to AN. Analysis of a cohort of 170 female Caucasian anorexia nervosa sufferers and 150 normal female controls shows evidence of association with the marker D11S911 but not D11S916. Allele 13 of the marker D11S911 is significantly over represented in the anorexia nervosa population suggesting that a mutation in linkage disequilibrium with this locus may form part of the genetic component of AN. Further work is now required to try to reproduce these data in a second independent cohort and to further characterise this region of the human genome.
Recently, there has been an upsurge of interest in the genetics of anorexia nervosa (AN). There is now more acceptance that this disorder, once thought of purely in psycho-social terms, has a sizeable genetic component. Data from Germany have failed to show association with a number of candidate loci. [1] [2] [3] However, the list of genes that might theoretically play a role in this disorder is far from exhausted.
It has been suggested that AN may involve an aberration in the serotonergic system. Recent data from Collier and colleagues 4 demonstrate a putative association between a polymorphism in the promoter region of the 5-HTR 2A gene and genetic predisposition to AN. However, we 5 and others 1 have been unable to confirm this initial observation. The debate regarding the involvement of this locus in the genetic predisposition to AN is still unclear and two further small studies also claim association at this locus. 6, 7 In the current study we focused on two further candidates, namely UCP-2 and UCP-3. The protein products of these genes are ubiquitously expressed and are thought to have a role in the control of energy expenditure and metabolic adaptation during fasting. 8 Several studies, including that of Moukaddem and colleagues, 9 describe the difficulty of inducing weight gain in AN patients, and that unusually high energy intakes are required to maintain a normal weight after refeeding. Indeed, these patients seem to maintain a low body mass with relative ease. Given the involvement of UCP-2 and UCP-3 in thermogenesis, the two corresponding genes are plausible candidates for a role in the genetic susceptibility to AN.
The genes for UCP-2 and UCP-3 co-localise to a 10.5 cR 3000 , or ෂ3-cM, region of human chromosome 11q13. Two highly polymorphic microsatellite markers have been identified within this region and have been shown to be linked to a number of physiological parameters including resting metabolic rate. Having identified a significant association between one marker at this locus but not the other, we wished to confirm that these two markers independently segregate within our population. Linkage disequilibrium analysis was performed on the genotype data from 127 individuals in our control data set. As predicted from the published genetic distance, formal statistical analysis failed to show significant disequilibrium between the two marker loci tested (P = 0.077).
Although it is still not possible to identify the precise mechanism through which this locus is involved in AN, these data suggest a possible role for one or both members of the UCP family located at this region of human chromosome 11q13. Further studies are now required to confirm these data in a second, independent cohort and to further characterise this locus.
Methods
A cohort of 170 sufferers (DSM-IV criteria) was obtained from the clinics of Dr Pieri. Sufferers were all British Caucasian females, referred to the Yorkshire Centre for Eating Disorders. Mean age of disease onset of this group was 18.1 yrs with a minimum average body mass index (BMI) of 13.73 kg m −2 during illness. The control cohort of 150 British caucasian females was obtained from a number of sources. Mean age of the controls was 30.28 yrs with an average BMI of . The latter were screened for a personal or immediate family history of an eating disorder or other psychiatric illness.
All individuals were asked to complete identical questionnaires covering demographic data, eating history, a history of their height and weight, menstrual history, personal and family history, and psychiatric history. These were independently assessed before inclusion into the study. Where appropriate, individuals also received a standard diagnostic interview and diagnoses were based on all available clinical information (including interview, case notes, questionnaire). Written informed consent was obtained, peripheral venous blood sampled and genomic DNA prepared by standard protocols. Approval for this study was provided by the Leeds (East) Medical Research (Ethics) Committee.
Fluorescent PCR primers were designed for markers D11S916 and D11S911 according to the published sequences. Radiation hybrid mapping of UCP-2, UCP-3, D11S916 and D11S911 confirms the order of these loci as D11S916-UCP-2-UCP-3-D11S911 (data not shown). Genotypes were determined by analysing fluorescently labelled PCR products on an ABI 377 DNA Sequencer. Statistical analysis were performed, using 'Clump 11 ', to identify any differences between allele frequencies at either marker, in the two populations.
Linkage disequilibrium analysis was performed by Derek Gordon, in collaboration with Jurg Ott, at Rockefeller University, New York, USA. To test for linkage disequilibrium between the two marker loci, a computer program was written to set up a contingency table of genotypes with rows and columns corresponding to genotypes at loci 1 and 2, respectively. After deleting rows and columns containing no observations, the resulting matrix of observations was analysed with the Fisher's statistic as implemented in the StatXact program (Cytel Software Corporation, Cambridge, MA, USA). The corresponding P-value was computed by a Monte Carlo method (Jurg Ott, personal communication).
